BlackRock, Inc. 13D and 13G filings for Novavax, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | Novavax, Inc. NVAX |
BlackRock Inc. BLK |
13,450,411 8.400% |
5,014,232 (+59.44%) |
Filing |
| 2024-01-26 4:23 pm Purchase |
2023-12-31 | 13G | Novavax, Inc. NVAX |
BlackRock Inc. BLK |
8,436,179 7.100% |
3,627,918 (+75.45%) |
Filing |
| 2023-02-01 4:54 pm Purchase |
2022-12-31 | 13G | Novavax, Inc. NVAX |
BlackRock Inc. BLK |
4,808,261 5.700% |
397,500 (+9.01%) |
Filing |
| 2022-03-11 2:13 pm Unchanged |
2021-12-31 | 13G | Novavax, Inc. NVAX |
BlackRock Inc. BLK |
4,410,761 5.800% |
0 (Unchanged) |
Filing |
| 2022-02-08 5:05 pm Sale |
2021-12-31 | 13G | Novavax, Inc. NVAX |
BlackRock Inc. BLK |
4,410,761 5.800% |
-726,870 (-14.15%) |
Filing |
| 2021-02-05 07:51 am Purchase |
2020-12-31 | 13G | Novavax, Inc. NVAX |
BlackRock Inc. BLK |
5,137,631 8.100% |
3,287,925 (+177.75%) |
Filing |